FOR Malaysia, the crisis in the Strait of Hormuz is not just an energy crisis; it is also a problem of access to medicine.
Malaysia is a net importer of pharmaceuticals. According to the Malaysian Investment Development Authority’s (Mida) pharmaceutical industry profile, imports rose from RM7.76bil in 2019 to RM11.30bil in 2023.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
